NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that the company is launching the process to identify a successor for Dr. Mikael Dolsten, Pfizer’s Chief Scientific Officer and ...
Pfizer, Inc. (NYSE:PFE) announced it is starting the process to find a new chief scientific officer and president of Pfizer Research and Development. The Details: Mikael Dolsten, the current Chief ...
Pfizer gains healthcare attention as expanded hemophilia approval broadens treatment use while organizational change shapes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results